VERONICA BARBOZA: Open Payments
NPI 1912689365 · CHELMSFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,468 in 101 payments from 20 companies in 2025. Trend: 2023 $100 · 2024 $1,040 · 2025 $2,468
Food & beverage: $2,468
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $461 |
| Madrigal Pharmaceuticals | 10 | $445 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $325 |
| Janssen Biotech, Inc. | 7 | $163 |
| Ipsen Biopharmaceuticals, Inc | 5 | $163 |
| GENZYME CORPORATION | 4 | $117 |
| Regeneron Healthcare Solutions, Inc. | 3 | $99 |
| PFIZER INC. | 4 | $85 |
| Ardelyx, Inc. | 5 | $80 |
| QOL Medical, LLC | 3 | $77 |
Products named: REZDIFFRA, ENTYVIO, DUPIXENT, TREMFYA, IQIRVO, RINVOQ, LINZESS, SKYRIZI.
Industry payments across MA — which companies pay providers there.
